Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pravastatin and cancer: an unproven association.

× No keyword cloud information.

12 in total

1. Statins and cancer risk: a meta-analysis.

Authors: Krista M Dale; Craig I Coleman; Nickole N Henyan; Jeffrey Kluger; C Michael White
Journal: JAMA Date: 2006-01-04 Impact factor: 56.272

2. Effect of pravastatin (10 mg/day) on progression of coronary atherosclerosis in patients with serum total cholesterol levels from 160 to 220 mg/dl and angiographically documented coronary artery disease. Coronary Artery Regression Study (CARS) Group.

Authors: A Tamura; Y Mikuriya; M Nasu
Journal: Am J Cardiol Date: 1997-04-01 Impact factor: 2.778

Review 3. Celecoxib and cardiovascular risks.

Authors: James M Brophy
Journal: Expert Opin Drug Saf Date: 2005-11 Impact factor: 4.250

4. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Authors: C Baigent; A Keech; P M Kearney; L Blackwell; G Buck; C Pollicino; A Kirby; T Sourjina; R Peto; R Collins; R Simes
Journal: Lancet Date: 2005-09-27 Impact factor: 79.321

5. Serum lipids, lipid-lowering drugs, and the risk of breast cancer.

Authors: A Heather Eliassen; Graham A Colditz; Bernard Rosner; Walter C Willett; Susan E Hankinson
Journal: Arch Intern Med Date: 2005-10-24

6. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study.

Authors: L Blais; A Desgagné; J LeLorier
Journal: Arch Intern Med Date: 2000 Aug 14-28

7. Does pravastatin promote cancer in elderly patients? A meta-analysis.

Authors: Stefanos Bonovas; Nikolaos M Sitaras
Journal: CMAJ Date: 2007-02-27 Impact factor: 8.262

8. Statins and the risk of colorectal cancer.

Authors: Jenny N Poynter; Stephen B Gruber; Peter D R Higgins; Ronit Almog; Joseph D Bonner; Hedy S Rennert; Marcelo Low; Joel K Greenson; Gad Rennert
Journal: N Engl J Med Date: 2005-05-26 Impact factor: 91.245

9. Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients.

Authors:
Journal: Am J Cardiol Date: 1993-11-01 Impact factor: 2.778

10. Why most published research findings are false.

Authors: John P A Ioannidis
Journal: PLoS Med Date: 2005-08-30 Impact factor: 11.613